Related Experiment Videos
[Phagocytic activity of monocytes in human primary glomerulonephritis]
Insights
Peripheral monocytes show reduced phagocytic activity in patients with primary glomerulonephritis (GN), indicating a potential mechanism for impaired circulating immune complex clearance.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Context:
- Circulating immune complexes (CIC) are a major cause of glomerulonephritis (GN).
- Phagocyte activity is crucial for clearing CIC and preventing glomerular damage.
- Nonsystemic GN pathogenesis involves factors beyond CIC composition and hemodynamics.
Purpose:
- To investigate the phagocytic function of peripheral monocytes in patients with primary nonsystemic GN.
- To determine if reduced phagocytic activity in GN is linked to serum factors.
Summary:
- Phagocytic activity, measured by phagocytic index and percentage, was significantly decreased in monocytes from patients with membranous GN, membranoproliferative GN, and lipoid nephrosis compared to controls.
- This reduced phagocytic function was consistent across both autologous and heterologous serum samples, suggesting the defect is intrinsic to the monocytes and not due to serum inhibitors.
- The findings indicate that impaired monocyte phagocytosis is a characteristic feature of certain primary GN types.
Impact:
- Identifies a potential cellular defect contributing to GN pathogenesis.
- Suggests that altered phagocytic activity may lead to insufficient clearance of CIC.
- Opens avenues for exploring therapeutic strategies targeting monocyte function in GN management.
Abstract:
Circulating immune complexes (CIC) account for a majority of GN. Their pathogenicity depends on size, molecular composition, glomerular hemodynamics and activity of phagocytes. The phagocytic function of peripheral monocytes was studied in 23 patients with nonsystemic GN. Phagocytic activity of peripheral blood monocytes was assessed in vitro, by calculating phagocytic index (IP: number of zymozan particles in each monocyte) and phagocytosis percentage (PP: number of phagocyting monocytes); the tests were carried out on autologous and heterologous serum samples. In 13 controls, PP was 79 +/- 5.8%. In 7 membranous GN, 6 membranoproliferative GN and 10 lipoid nephrosis, PP was severely decreased, 63.4 +/- 9.6%, 52.1 +/- 19% and 52.2 +/- 14%. In each group of GN, these results were significantly different from controls (p less than 0.01). In all groups these results were similar in autologous and heterologous serum samples (55 +/- 13% and 57.5 +/- 16%; NS). Therefore, this defect was not linked to the presence of serum inhibitors. In conclusion, alterations of phagocytic activity is present in some primary GN and may explain an insufficient rate of CIC removal.